ArticleFrontiers in immunology2020

Therapeutic Targeting of Retinal Immune Microenvironment With CSF-1 Receptor Antibody Promotes Visual Function Recovery After Ischemic Optic Neuropathy.

Yizhen Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.